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ABSTRACT
One of the most intriguing aspects of cell biology is the state of pluripotency, where the cell is capable
of self-renewal for as many times as deemed “necessary”, then at a specified time can differentiate into
any type of cell. This fundamental process is required during organogenesis in foetal life and
importantly during tissue repair in health and disease. Pluripotency is very tightly regulated, as any
dysregulation can result in congenital defects, inability to repair damage, or cancer. Fuelled by the
relatively recent interest in stem cell biology and tissue regeneration, the molecules implicated in
regulating pluripotency have been the subject of extensive research. One of the important molecules
involved in pluripotency, is NaNog, the subject of this article.
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INTRODUCING ‘NANOG’
‘And our souls were young again in Tir Na Nog’ sings the Irish songwriter and musician Van Morrison in
one of his famous songs, referring to the Irish Legend of Oisı´n and Niamh and the Land of Eternal
Youth, beauty, health and joy - Tı´r Na nO´g (Fig. 1). Inspired by the land of Tı´r Na nO´g, the divergent
homeobox transcription factor that plays a crucial role in embryonic stem (ES) cell fate specification
and self-renewal was coined Nanog. In 2003, Nanog was introduced in two papers published in the
same issue of Cell and was celebrated as the ‘new recruit to the ES cell orchestra’.1–3
Until its discovery, knowledge of what defines the potency of mouse embryonic stem cells revolved
around a quartet of transcription factors; Oct4, Sox2, FoxD3, and Stat3.
Oct4 is required for cell fate regulation in the early embryo, is expressed in the inner cell mass (ICM),
and is down regulated upon differentiation into trophoblast cells .4 Sox2 and FoxD3 are known to be
involved later in the maintenance of the epiblast after implantation .5,6 Stat3 activation by the cytokine
Leukemia Inhibitory Factor (LIF) is required to sustain self-renewal of cultured ES cells.7–9
Chambers et al. and Mitsui et al. did not only describe the homeobox transcription factor Nanog and
its expression in the inner cells of a compacted morula, blastocyst, early germ cells and in the ES and
embryonic germ (EG) cell lines derived from these stages, they also showed how embryo cell fate
specification and ES cell self-renewal may be related.
THE VARIANTS OF NANOG
The Nanog gene is related to the NK homeobox genes first described by Kim & Nirenberg in
Drosophila10 and shows close sequence alignment with the transcription factors Msx1, Nkx2.5 and
Barx1 (50% amino acid identity in the protein’s homeodomain). NANOG promoter region, 299 bp large
Figure 1. The Irish Legend of Oisı´n and Niamh and the Land of Eternal Youth, beauty, health and joy - Tı´r Na nO´g:
[ . . . ] As the beautiful woman and her horse drew nearer, all the men (great warrior Oisı´n with his father the
legendary Finn MacCool the leader of the Fianna – a group of great protectors who guarded the High King of
Ireland) stopped in their tracks, waiting to hear what she had to say. “My name is Niamh,” said the goldenhaired
maiden, “my father is the King of the mystical land of Tı´r Na nO´g, a land that knows no sorrow andwhere nobody
ever ages. I have heard wonderful things of a great warrior named Oisı´n, and I have come to take him with me
back to the Land of Eternal Youth.” Oisı´n immediately fell in love with Niamh and agreed to join Niamh on
horseback to go and live in Tı´r Na nO´g, promising his father that he would return to Ireland to see him again
soon.[ . . . ] Source: http://irelandofthewelcomes.com
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(2264 to þ35) upstream of exon 1 contains five CpG-dinucleotides, which are subjected to
DNA-methylation11. This NANOG promoter region also contains an OCT3/4-SOX2 binding motif, a
TATA-box and binding sites for the transcription factors AP-2, SP1 and TFIID.11,12 There are four transcript
variants of the mRNA encoded by NANOG: Transcript variants NANOG-001 (2101 bp mRNA) and 2002
(870 bp mRNA) are known as protein coding, while variant 2 004 (561 bp mRNA) is putatively protein
coding and variant 2 003 is known as nonsense mediated decay. NANOG transcription can be
regulated by binding of OCT3/4 and SOX2 to their binding motifs in the NANOG promoter.11– 13 Eleven
Nanog pseudogenes - a large number for a homeobox gene (more details on this are described in the
next paragraph) - have been described in the human genome.14 Ten are processed (NANOGP2 -
NANOGP11) and one is a non-functional duplication (NANOGP1) genome.
IT’S A HOMEOBOX (NOT A HOX) GENE
In humans, the NANOG gene is located on the short arm of chromosome 12 (12p13.31) from 7940390 –
7948655 and encompasses 8265 bp of DNA. NANOG is a homeobox gene. Homeobox genes are a
group of genes with a common DNA sequence that are involved in body segmentation and cell
differentiation during embryonic development. They contain a 180-base-pair segment (the
“homeobox”) that encodes a 60 amino acid DNA-binding protein domain called the homeobox domain
or homeodomain. The homeodomain binds DNA and acts as a transcription factor that regulates
expression of a number of target genes. It was first identified in a number of homeotic and
segmentation proteins in the fruit fly Drosophila Melanogaster.15,16 In 1995 the Nobel Prize in
Physiology or Medicine was awarded to Ed Lewis, Christiane Nu¨sslein-Volhard and Eric Wieschaus for
the identification and classification of 15 genes of key importance in determining the body plan and the
formation of body segments of Drosophila, the Hox genes. “Homeotic mutations” of the Hox genes
Figure 2. The effects of mutations in homeotic genes. The first Homeobox genes discovered were Drosophila
melanogaster developmental control genes that specify the identity of each body segment by controlling the
identity of the organs that develop within that segment, the HOX genes. They were described as “homeotic”
genes. “Homeotic” is a functional description for genes that cause homeotic transformations. All homeotic
genes are transcriptional regulators. In Drosophila numerous ‘homeotic transformations’ were observed, where
e.g. body parts seem to have been replaced by other. Known homeotic mutations cause the formation of an extra
set of wings, or two legs at the position in the head where the antennae of a Drosophila are normally found.
(a) Normal Drosophila head. (b) Drosophila homeotic mutant (Antennapaedia): antennae are replaced by
legs. (c) Normal Drosophila body structure. (d) Homeotic mutant (Bithorax): segment has developed incorrectly
to produce an extra set of wings. Images are courtesy of the Archives, California Institute of Technology.
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cause “homeotic transformations”, where for example body parts seem to have been replaced by other
(Fig. 2). Even though the homeodomain binds DNA in a sequence-specific manner, homeodomain
proteins mostly act in the promoter region of their target genes as complexes with other transcription
factors, which provides higher target specificity than the homeodomain protein alone. Homeodomains
are encoded by different clusters of Homeobox genes, e.g. the Hox-, the ParaHox- and the NK gene
clusters.
NANOG’S SIGNATURE STRUCTURE
NANOG-001 (referred to as Nanog_human or Nanog in this review) is a 305 aa long protein with a
molecular weight of 34.6 kDa usually analyzed to study the role of NANOG. It is a multidomain protein
with a well-conserved Nk-2 homeodomain.1,2,17,18 N-terminal region contains 95 residues rich in Ser
and Thr and acidic residues found in typical transactivators.1,2,17 The signature homeodomain spans
from aa 95-155 and facilitates DNA-binding and gene regulation and interaction with other
proteins.17,19,20 Formation of secondary structures (helix, strand and turn) occurs mainly within the
homeobox-coding region. C-terminal to the homeodomain, Nanog contains a tryptophan repeat (WR)
domain in which every fifth residue is a tryptophan. Reports from two laboratories reveal that the WR
domain mediates Nanog dimerization and is required to confer LIF-independent self-renewal in ES
cells.21,22 A Nanog mutant with an alteration of 20 tryptophans to alanines within the WR domain lost
the capacity to interact with several other pluripotency network proteins, including Sall4, Zfp281,
Zfp198 and Dax1.22 The WR domain is conserved in the placental mammalian orthologues of Nanog.
The NANOG protein is unstable with a half-life of 120min in human ES cells, a characteristic of proteins
involved in tightly controlled interaction networks.23
THE ROLE OF NANOG IN MAMMALIAN EMBRYOLOGY
Embryonic development in a nutshell
The development of the mammalian embryo involves a series of cleavage divisions and cell fate
determinations that are tightly regulated at each developmental stage. For example, the transition from
the compacted morula to the early blastocyst stage is accompanied by a strict separation of two cell
lineages of the embryo, namely the trophoectoderm, which is the extra-embryonic structure that gives
rise to the trophoblast lineage, and the inner cell mass (ICM), which produces all embryonic tissues.
Contrary to the committed cells of the trophoectoderm, cells of the ICM are pluripotent and hence are
able to generate ES cells in vitro or develop into the embryo founder tissue, known as the epiblast,
in vivo.24–26 In addition, a subset of the ICM cells differentiate into another extra-embryonic layer
referred to as the primitive endoderm to further support the developing embryo.
Nanog “masters” the specification of ES cell identity
In an attempt to develop a deeper understanding of embryonic development, research studies have
focused on uncovering key genes that are involved in lineage specification and pluripotency.
As mentioned earlier, loss-of-function studies have identified Nanog as the main player in maintaining
the pluripotency of the ICM in vivo, self-renewal of ES cells in vitro as well as driving the development of
the subsequent pluripotent epiblast into the germ cell lineage.1,2
The significant role of Nanog in maintaining pluripotency was highlighted when the main players in
pluripotency, Oct3/4, Sox2 and Stat3, failed to support LIF-independent self-renewal in ES cells.1,2
Both ES cells in vitro and pluripotent epiblast cells in vivo require both Oct3/4 and Nanog to evade
differentiation into extra-embryonic lineages and additional factors such as LIF-activated Stat3 prolong
their pluripotent potential. In the absence of Oct3/4, ES cells lose their pluripotent capacity and
differentiate into the trophoectoderm.27 Surprisingly, Niwa et al. have shown that elevating the
expression of Oct3/4 in ES cells beyond the endogenous level triggers their differentiation into the
primitive endoderm.28 Therefore, these conflicting roles of Oct3/4 suggest that it plays a significant role
in cell fate determination by tightly regulating a broad range of genes during the early stage of
embryonic development. As opposed to Oct3/4, Nanog has been shown to maintain the pluripotency
of ES cells even in the absence of the LIF/Stat3 pathway.1,2 In the absence of LIF, Oct3/4 is unable to
prevent ES cells from differentiating into the trophoectoderm lineage and even elevating Oct3/4 levels
does not rescue pluripotent ES cells from reverting back to a differentiated state. Increasing the
expression of Nanog, on the other hand, circumvents the need for LIF/Stat3 expression to block ES cells
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differentiation into the primitive endoderm and supports ESC self-renewal.2 These findings define
Nanog as a “master” player in the specification of ES cells identity, superseding the roles of Oct3/4 and
LIF/Stat3 in maintaining pluripotency (Fig. 4).
Nanog is a crucial pluripotency-sustaining factor in the pre-implantation embryo
But how does Nanog determine cell fate in the ICM of the pre-implantation mammalian embryo? A
study by Loh et al., 2006 has shown that Nanog-deficient mouse embryos tend to generate pluripotent
cells in the initial phase of development but then suddenly differentiate into the primitive endoderm.27
This indicates that the effect of Nanog in maintaining pluripotency becomes crucial at a later stage in
embryonic development after Oct3/4 has regulated cell fate in the initial phase. In fact, Mitsui et al.,
Figure 3 (A). 1) UniProtKB sequence of NANOG_HUMAN with secondary structure motifs, Length 305 aa.
2) UniProtKB chains with UniProtKB sequence motifs. 3) Predicted regions of protein disorder based on Jronn
(Troshin, P. and Barton, G. J. unpublished), a Java implementation of RONN (Ref). Red: probably disordered,
Blue: probably ordered. 4) Hydropathy has been calculated using a sliding window of 15 residues and summing
up scores from standard hydrophobicity tables. Red: hydrophobic, Blue: hydrophilic. 5) Exome boundaries
mapped from chromosomal coordiantes onto UniProt Sequence. Figure adapted from RCSB PDB Data base. Data
Source: 1, 2 and 3: UniProtKB, 4 and 5 were calculated using BioJava. (B) Molecular models of Nanog homeobox.
1) A 3D cartoon illustration of dimer state of Nanog homeodomain (HD) with DNA strands. 2) The monomer model
of HD with DNA and the extended figure panel at the bottom shows a close-up view of the key residues at their
interface. 3) The surface (white) map of monomeric HD provides an external interaction pattern of the complex.
All the models are created using the 3D data of crystal structure of a nanog homeobox from human and the data
was retrieved from protein data bank (ID: 4RBO). The molecular artworks are prepared with PyMOL.
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2003 showed that Oct3/4 tends to be highly expressed whereas Nanog levels remain low during the
early stage of embryonic development; specifically at the morula stage.2 Similar to ES cells, the
expression of Oct3/4 at this stage is critical for maintaining pluripotency. The expression pattern of
Nanog changes dramatically as the pre-implantation embryo progresses into the early blastocyst stage
(E3.5), the point at which Nanog becomes the key determinant of cell fate.2 While Oct3/4 expression is
more broadly expressed in the mouse embryo at E3.5, Nanog expression is restricted to the subset of
ICM cells that will eventually give rise to the pluripotent epiblast during the late blastocyst stage
(E4.5).24,29,30 The remaining cells of the ICM that do not express Nanog have been shown to exclusively
express endoderm-specific genes, such as Gata4/6, which drive their differentiation into the primitive
endoderm at E4.5.25,31 Taken together, these findings identify Nanog as the major lineage specification
factor maintaining the pluripotency of ICM cells throughout the E3.5 to E4.5 transition.
Nanog and chromosome X-reactivation
Female mammals have two gene-rich X chromosomes whereas the male has a single x chromosome
and a Y chromosome, which carries a limited amount of genes.32 If both X-linked genes were equally
expressed, females would express twice as many X-linked genes as would males creating an imbalance
between both sexes. Therefore, female placental mammals have developed a strategy of
X-chromosome inactivation (XCI) to resolve the X-linked dosage discrepancy between both sexes. The
mechanism of XCI enables one of the two X chromosomes in the female to be transcriptionally silenced
in a completely random manner; that is, both maternal and paternal X chromosomes have an equal
chance of being inactivated.33,34 However, at what stage of embryonic development does the X
chromosome become silenced and how is it regulated? Studies performed on mouse ES cells, in which
the mechanism of XCI can be recapitulated, have revealed new insights into this unique
phenomenon.33
XCI takes place initially at the early blastocyst stage (E3.5) where the paternal X chromosome is
preferentially silenced.34,35 The progression into the last blastocyst stage (E4.5), however, is
accompanied by a reactivation of the silenced paternal X chromosome specifically in the pluripotent
epiblast in order to subsequently allow either the maternal or paternal X to be randomly inactivated in
the female embryo.34,36 Trophoblast cells, on the other hand, retain the inactivated form of paternal X
chromosome throughout embryonic development.25,34 These results suggest that X-reactivation could
serve as a marker for ground state pluripotency. In fact, studies have shown that at E3.5, the subset of
ICM cells expressing Nanog - the “master” gene of pluripotency - are able to reactivate the silenced
paternal X-chromosome as they progress into E4.5.25 Expectedly, the subset of Nanog-negative ICM fail
to reactivate the paternal X-chromosome at E3.5, which explains why cells of the primitive endoderm
and trophoectoderm lineage retain the silenced form of the paternal X chromosome throughout
development.25 Hence, these findings suggest that Nanog couples pluripotency of epiblast cells with
X-reactivation; however, the exact mechanisms require further investigation.
Figure 4. The contribution of Nanog, Oct3/4 and LIF/Stat3 during embryonic development. Oct3/4 facilitates the
development from the morula into the early blastocyst stage (E3.5) by inactivating trophoectoderm
differentiation. Nanog mediates the transition of pluripotent inner cell mass (ICM) cells into epiblast cells
between E3.5 and E4.5 in vivo. Additionally, Nanog-expressing ICM cells are able to generate pluripotent ESCs
in vitro. Nanog supports ESC self-renewal in a LIF/Stat3 independent manner.
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A “master gene” for molecular reprogramming?
Similar to pluripotent epiblast cells, reprogrammed induced pluripotent stem cells (iPSCs), the subject
of this section, re-activate the paternal X chromosome.33 Hence, X-reactivation could serve as a marker
for pluripotency. The discovery of iPSCs was initiated by Takahashi and Yamanaka in 2006 when they
reported a revolutionary approach in the field of stem cell biology whereby differentiated cells could be
re-programmed into a pluripotent state via exogenous expression of 4 transcription factors (Oct4, Sox2,
Klf4 and c-Myc).37 Sharing similar morphological and functional properties with ES cells, iPSCs have
opened up new avenues for regeneration therapies. Surprisingly, Nanog was not included in the
quartet of pluripotency-promoting transcription factors. However, ensuing studies suggested that the
function of Nanog during the reprogramming process might be analogous to its crucial role in
establishing pluripotency in ICM cells.25
Nanog converts pre-pluripotent cells into fully reprogrammed iPSCs
Studies have shown that Nanog-deficient ICM cells fail to develop into epiblasts and are unable to give
rise to ESCs. Instead, they are locked in a pre-pluripotent state leading to apoptotic behavior.2,25,38
Knock down of Nanog in established ES cells, on the other hand, does not alter their self-renewal
capacity or their ability to differentiate into germ cell lineages.1 Similarly, Nanog-deficient pre-iPSCs fail
to achieve a pluripotent ground state and are non-viable, whereas deletion of Nanog in fully
reprogrammed iPSCs has no effect on their pluripotent potential.39,40 These findings suggest that
Nanog’s role during molecular reprogramming could be dispensable during the initiation process;
which is achieved by the quartet to generate partially reprogrammed pre-iPSCs, but later becomes
crucial to produce bona fide iPSCs (Fig. 5).40,41 In fact, a study by Lee et al., 2013 showed that
miR-302-mediated knock down of methyl-DNA binding domain protein 2 (MBD2), which
transcriptionally inactivates Nanog, significantly enhances the reprogramming efficiency of pre-iPSCs
by increasing Nanog expression.
Nanog cooperates with reprogramming factors and epigenetic regulators to achieve ground
state pluripotency
How does Nanog facilitate the transition of pre-iPSCs into ground state pluripotency? Chromatin
immunprecipitation studies have shown that in fully reprogrammed iPSCs Nanog forms protein
complexes with Oct4, Sox2 and Klf4 at promoter targets that are also occupied by Nanog in ES
cells.42–44 Therefore, the transition from the pre-iPS to the iPS state requires Nanog-mediated
recruitment of the reprogramming factors to promoters of the pluripotent genes or Nanog-induced
epigenetic remodelling of these sites rendering them accessible to the exogenous transgenes. These
findings suggest that Nanog acts as a “master gene” orchestrating the molecular switch to a purely
undifferentiated state. Interestingly, recent evidence has revealed new insights into the role of Nanog in
reprogramming. For example, Schwarz et al., 2014 reported that minor changes in iPS culture
conditions could circumvent the need for Nanog to produce bona fide iPSCs.45 The authors were able
to show that the addition of ascorbic acid to iPS medium facilitates the transition of Nanog-deficient
mouse embryonic fibroblasts (MEFs) into fully reprogrammed iPSCs that functionally resembled
wild-type iPSCs. This finding suggests that iPSC generation could be achieved via distinct yet
Figure 5. Requirement of Nanog during the reprogramming process. Partial reprogramming of a differentiated
cell into a pre-iPSC is achieved by the exogenous expression of the reprogamming factors (Oct4,Sox2,Klf4,
c-Myc). Nanog is dispensable at this stage. The conversion of pre-iPSCs into bona fide iPSCs is dependent upon
Nanog expression. Inactivation of Nanog at this stage does not alter the self-renewal capacity of iPSCs.
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redundant pathways. Therefore, further studies are warranted to elucidate the different mechanisms by
which fully reprogrammed iPSCs could be generated.
Conclusion and future directions
Successful translation of the recent advances in stem-cell research to the clinical arena depends
profoundly on careful understanding of the complex biological networks governing cell repair and
regeneration. Elucidating the role of master molecules, i.e. molecules that regulate mass gene
transcription such as Nanog, is a crucial step in deciphering these networks. While our understanding
of Nanog’s role in embryogenesis has grown tremendously over the past few years, further research on
its role in inducing and maintaining pluripotency in adult life is needed. Until then, the quest for
Tı´r Na nO´g continues.
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